ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001285.1|Pseudopyronine_1 # 3 # 476 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.660	BGC0001285.1|Pseudopyronine_1 	3	476	+	Loose	600	25.409	EstT	50.0	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	AACGCCATGGACATCAGCCACGCCAGTTCATCGCCCCACGGCCTGCGTTTCTACTGGAACCGCCTCGCCGAACAGCTGCAACGCCTGCTTGGCGACAGCGTCCTGTGCCTGGTCGCCCGCCTGGGCATCGCCTCGATCTTCTTTCTGTCCGGTCGGACCAAGGTCGAAGGCCTGCTGAGCATCACCCCCGGCACCTACGAGCTGTTCCAGAGCGAGTACGCCTTGCCGCTGGTGTCACCCTGGCTGGCGGCGCACCTGGCGACCTACGCCGAGCACCTGTTCCCATTGTTGCTGGTGCTCGGCCTGCTCACCCGGCTGTCAGCCCTGGCCCTGCTGGGCATGACCCTGGTGATCGAGATCTTCGTCTATCCGGACGCCTGGCCCACCCACCTTTCCTGGGCCGGCCTGCTCCTGCTGCTGATCGCCCGGGGCGGCGGTGCACTGTCCCTGGACCGGGTATTGCGCTTGCGTTAA	NAMDISHASSSPHGLRFYWNRLAEQLQRLLGDSVLCLVARLGIASIFFLSGRTKVEGLLSITPGTYELFQSEYALPLVSPWLAAHLATYAEHLFPLLLVLGLLTRLSALALLGMTLVIEIFVYPDAWPTHLSWAGLLLLLIARGGGALSLDRVLRLR	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	51.31	gnl|BL_ORD_ID|4956|hsp_num:0	5948			678	744	tigecycline
BGC0001285.1|Pseudopyronine_2 # 526 # 2718 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0001285.1|Pseudopyronine_2 	526	2718	-	Loose	850	26.5646	mepA	26.09	3000026	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGAAATCAAGGTCAATTTTCTCGACAACCTTCGTCTCGAAGCCAAGTTCGACGACTTCACGGTGATCGCCGACCAGCCGATCCGCTACAAGGGCGACGGCTCGGCCCCGGGGCCGTTCGACTACTTCCTGGCGTCGTCGGCGCTGTGCGCGGCGTACTTCGTCAAGCTGTACTGCCAGACCCGCGATATTCCGACCGAGAACATCCGCCTGTCGCAGAACAACATCGTCGACCCCGAGAATCGCTACAACCAGATCTTCAAGATCCAGGTCGAGCTGCCCGAGGACATCTCCGAGAAGGACCGCCAGGGCATCCTGCGCTCCATCGACCGCTGCACCGTGAAGAAGGTGGTGCAGACCGGCCCCGAGTTCATCATCGAGCAGGTCGACAACCTCGACGCCGACGCCCAGGCGCTGCTGATGCCGGTGTCGGATACCAGCACCTACATTCCGGGCAAGGACCTGCCGCTGGAGCAGACCATCGCCAACATGTCGGCGATCCTCGCGGGCCTGGGGATGAAGATCGAGATCGCCTCCTGGCGCAACATCGTGCCCAATGTCTGGTCGCTGCACGTGCGCGACGCGCAGTCGCCGATGTGCTTCACCAATGGCAAGGGCGCGACCAAGGAAGCGGCGCTGGCCTCGGCGCTGGGCGAGTTCATCGAGCGGCTGAACTGCAACTTCTTCTACAACGACCAGTTCTGGGGCGAGGACATCGCCAATGCGGCGTTCGTGCACTACCCCAACGAGCAGTGGTTCAAGCCAGGACCCAAGGACGCGCTGCCGGCCGAGATCCTCGACGAGCACTGCCTGCAGATCTTCAACCCCGACGGCGAGCTGCGCGGCTCGCACCTGTACGACACCAACTCGGGCAACAAGGAGCGTGGCATCTGCTCGCTGCCGTTCGTGCGCCAGTCGGACGGCGAGACGGTGTACTTCCCGTCCAACCTGATCGAGAACCTGTACCTGAGCAACGGCATGAGCGCCGGCAACACTCTGGCCGAGGCACAGGTCCAGTGCCTTTCGGAAATTTTCGAGCGAGCGGTCAAACGCGAGATCCTCGAAGGCGAGCTGTGCCTGCCGGACGTGCCGCAGGAGGTGCTGGCCAAGTACCCGGGCATCGTCGCCGGCATCCAGGGGCTGGAGGAGCAGGGCTTCCCTGTGCTGGTCAAGGACGCGTCGCTGGGCGGTGAGTTCCCGGTGATGTGCGTGACCCTGATGAACCCGCGCACCGGCGGCGTGTTCGCCTCGTTCGGCGCCCATCCGAGCTTCGAGGTGGCGCTGGAGCGCAGCCTCACCGAACTGCTCCAGGGCCGCAGCTTCGAGGGCCTGAACGACCTGCCGCAGCCGACCTTCGACAGCCTCGCGCTGACCGAGCCGAACAACTTCGTCGAGCACTTCATCGACTCCAGCGGCGTGGTGTCGTGGCGCTTCTTCGGCGCCAAGGCCGACTTCGAGTTCGTCGAGTGGGACTTCTCGGGCCACGGCGAGGACTCCAACCAGCAGGAGGCGCAGACCCTGTTCGGCATCCTCGAGGACCTGGGCAAGGAGGTGTACATGGCCGTGTACGATGACCTTGGCGCCACTGCCTGCCGTATCCTGGTGCCGGGTTATTCCGAGATCTACCCGGTCGAGGACCTGATCTGGGACAACACCAACCGCGCGCTGGGGTTCCGTGCCGATATCCTCAACCTGCACAAGCTGGACAATCGTTCGCTGAAGCTGCTGCTCAAGCGCCTGGACAACGCCGAGGTGGATGACTACACCACCATCACCACGCTGATCGGCGTCGAGTTCGACGACAACACGGTGTGGGGCCAGCTGACCATCCTCGAGCTGAAGCTGTTGATCCACCTGGTGCTGCAGCGTTTCGAGGAGGCCAAGGAGTTGGTCGAGATGTTCCTGCAGTTCAACGACAACACTGTCGAGCGCGGGCTGTTCTACCAGGCGTTGAACGTGGTGCTGGAGGTGGTGCTGGACGATGAGCTGGAGATGGCCGACTACGAGCACAACTTCCGTCGCATGTTCGGCAATGAGCGGATGGACGCGGTGCTGGGCTCGGTGGACGGCAGCGTCCGGTTCCATGGGTTGACGCCGACCAACCTGCAGCTCGAGGGACTGGATCGCCACCTGCGCCTGGTGGAGAGCTACAAGAAGCTGCACGCGGCGCGGGCGCGGGCGGCAGGGCTCTGA	MEIKVNFLDNLRLEAKFDDFTVIADQPIRYKGDGSAPGPFDYFLASSALCAAYFVKLYCQTRDIPTENIRLSQNNIVDPENRYNQIFKIQVELPEDISEKDRQGILRSIDRCTVKKVVQTGPEFIIEQVDNLDADAQALLMPVSDTSTYIPGKDLPLEQTIANMSAILAGLGMKIEIASWRNIVPNVWSLHVRDAQSPMCFTNGKGATKEAALASALGEFIERLNCNFFYNDQFWGEDIANAAFVHYPNEQWFKPGPKDALPAEILDEHCLQIFNPDGELRGSHLYDTNSGNKERGICSLPFVRQSDGETVYFPSNLIENLYLSNGMSAGNTLAEAQVQCLSEIFERAVKREILEGELCLPDVPQEVLAKYPGIVAGIQGLEEQGFPVLVKDASLGGEFPVMCVTLMNPRTGGVFASFGAHPSFEVALERSLTELLQGRSFEGLNDLPQPTFDSLALTEPNNFVEHFIDSSGVVSWRFFGAKADFEFVEWDFSGHGEDSNQQEAQTLFGILEDLGKEVYMAVYDDLGATACRILVPGYSEIYPVEDLIWDNTNRALGFRADILNLHKLDNRSLKLLLKRLDNAEVDDYTTITTLIGVEFDDNTVWGQLTILELKLLIHLVLQRFEEAKELVEMFLQFNDNTVERGLFYQALNVVLEVVLDDELEMADYEHNFRRMFGNERMDAVLGSVDGSVRFHGLTPTNLQLEGLDRHLRLVESYKKLHAARARAAGL	MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHHMVGLFTTDQAIVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG	161.86	gnl|BL_ORD_ID|344|hsp_num:0	377			609	735	tigecycline
BGC0001285.1|Pseudopyronine_3 # 2754 # 3560 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.658	BGC0001285.1|Pseudopyronine_3 	2754	3560	+	Loose	600	27.7202	BCL-1	31.25	3004749	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BCL Beta-lactamase	ATGGCGGGCATTATCCGGGATTTTTGCCGGAAAGTGTTGGCCTGCGACGAGCTGGGGATTGCTGCCCCTCGCAAAAGCCAGCCGTGCTTACTACGCTGGGTCATCGACAGGGAGAGCGAGACGACAATGCCCCATCACGCGACACTTCAGCAGGCCGGTTACGTCCTGCTTCGCCAGGCCGTCCCCCAGGGATGGCTGGAAGAACTGCGCCATGTGTTCGAGGCCGGGGTGAAACCTGCGCGGCAGTGGCCAGTGCCGCGCGCCAGCGACTGGCGTCACTCGCAACTGGACTGCGCCAAGCGGGTCCAGGCGGTCTGCCGCCTGCCGCAGTTGCTGGCAGCGGTGGGCGCGCTGATCGGCGAACGGTTCTTTCTCTACCAGGTGGAGGGCCGTGCCCCCGTGGCGGGTGGCGGCCACCAGGCGCTGCATCGCGATCTGTCGATGCAGCGGCCGGGCGACCTGGTGGGTGTCATGGTCTATCTGGACGACTACGGCCCGCAGAACGGCGCCACCCGCATTGTCCCTGGCAGCCACCGGCCTGAACCTGGCGAGACGCCCTTCGACTACAGCGACGAATCCCGGAGCCTTCACCTGTCGGGGCGCGCGGGGGATGCCCTGGTGTTCGATGTAGACCTGGTGCATGCCGCCAGCCTGAATGCCAGCGGCGCGCCGCGCCGCGCCTTGCTCATCGGCTATGCCGCCGAACCGCTCCAGGTGGCACTTCAGCAAACCGAGCATTTGCGCAATGTGCACATGAACACGCAGGAATGCTTCGAACCCTCGGACTACGTGTTCACAGCACCATGA	MAGIIRDFCRKVLACDELGIAAPRKSQPCLLRWVIDRESETTMPHHATLQQAGYVLLRQAVPQGWLEELRHVFEAGVKPARQWPVPRASDWRHSQLDCAKRVQAVCRLPQLLAAVGALIGERFFLYQVEGRAPVAGGGHQALHRDLSMQRPGDLVGVMVYLDDYGPQNGATRIVPGSHRPEPGETPFDYSDESRSLHLSGRAGDALVFDVDLVHAASLNASGAPRRALLIGYAAEPLQVALQQTEHLRNVHMNTQECFEPSDYVFTAP	MKRSFFMLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAARLGVFALDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNYNPITENHVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERIEPELNHVEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGVPEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLLAQTE	87.30	gnl|BL_ORD_ID|2374|hsp_num:0	3559			627	732	
BGC0001285.1|Pseudopyronine_4 # 3547 # 3684 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.645	BGC0001285.1|Pseudopyronine_4 	3547	3684	-	Loose	300	21.1718	AAC(3)-VIIa	47.06	3002541	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGATGCTGCAATCCGCCTGCGCCGGGCCATGCTCGACGACGCCGATGAAGTTGCCGTCCTGGTTGCAGCGGCCTACAGCCCCTACATCGCGAGGATCGGTCGGGTGAATGGCAGGCTCCCGGTCATGGTGCTGTGA	MDAAIRLRRAMLDDADEVAVLVAAAYSPYIARIGRVNGRLPVMVL	MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDVVGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRRPGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALTLLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEIIGRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG	15.62	gnl|BL_ORD_ID|597|hsp_num:0	653			291	342	paromomycin
BGC0001285.1|Pseudopyronine_5 # 3692 # 3889 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.611	BGC0001285.1|Pseudopyronine_5 	3692	3889	-	Loose	560	21.557	OXA-459	38.71	3003615	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCTCGACCCCACCCAACGGCCTGCCGGTCTATCGCCTGATCACCGGCAAGGACGACGCCAGTTTCTGCCAGCGTATTTCCGAGAGCCTGGCCTTGGGCTATCAGCTTCATGGGTCGCCCAGTGTGACCTTCGATAGCAGCAAGGGACATGTAGTGGCTGCTCAAGCGGTGCTGTGGCCGGTAGTCAGGGACTGA	MPSTPPNGLPVYRLITGKDDASFCQRISESLALGYQLHGSPSVTFDSSKGHVVAAQAVLWPVVRD	MTVRLSSCALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPDYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLPVKAAAYDLAENLFEVGEAGGWRLHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	23.64	gnl|BL_ORD_ID|2535|hsp_num:0	3526			591	684	cloxacillin; oxacillin; cefalotin
BGC0001285.1|Pseudopyronine_6 # 4283 # 6079 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0001285.1|Pseudopyronine_6 	4283	6079	-	Loose	1900	29.6462	MexI	40.0	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGCCCACATCGAAGACTACGCCCTCATCGGCAACTGCCGTAGCGCCGCCCTGATCAACCGCGACGGCGCCCTCGACTGGCTGTGCCTGCCACGCTTTGATGCTCCCGCGGTGTTCGCCGCGCTGCTGGGCAACGAGGAAAACGGCCGTTGGCGCATCGCCCCCAGCGACCCGGTCGAGCACAGCGCGCGCCGCTACCTCGACGACACCCTGGTACTGGAAACCACCTGGACCACCGCCAGTGGCCGCGCCCGGGTGCTCGACTGCATGCCGTTGGGCGAGCGCAACGCCGTGCTGCGCATCGTCGAGGGCCTGGCCGGCGAGACGGCCTTCGAGATGGACTTGGTGCTGCGCTTCGACTACGGCCGCAGTGTGCCCTGGGTGGAAAAGATAGACCCGCTGACCCTGAGCGCCGTCGCCGGTCCCGATCGGCTGATCCTGCGCAGCAGCACCGAAATCCATGGCCGCGACCACCACAGCGTCGCCCGTTTTCGCGTGGGCGCGGGGCAGCGCCAGGTATTCAGCCTCTGCCACCAGGCCTCGCACCTGCCCGTGCAGCCCGAATGCGACATTGACCACGACTTCGAACAGACCCTGGAGCAGTGGCGCGCCTTCGCCGCCCGCTGCCCTGATGTCGGGCCTTACACCGACCGGGTACGTCGTTCGCTACTGACCCTCAAGGCCATGACCTACGCGCCCACTGGCGGCATGGTCGCCGCCGTCACCACCTCGCTGCCCGAGCGCGTCGGCGGCGAGCGCAACTGGGACTACCGCTACTGCTGGCTGCGCGACGCCACCATGACCCTGCTGGCGTTGATGAACCTGGGCTACTTCGACGAGGCCCAGGCCTGGCGCGAATGGCTGCTGCGCTCGGTGGCCGGCAACCCCGAGCAGATGCAGATCATGTACGGCCTGGCGGGGGAGCGGGATCTTCCCGAGTTCACCTTGCCCTGGCTGCCGGGTTACGAGGGCTCGCAACCGGTTCGGGTCGGCAATGCCGCCGCCGGGCAGTTGCAGCTGGACATCTACGGCGAACTGGCCGACGCCATGACCCAGGCCATCAAGGGCGGGCTGCCGCGCCACTCGCGCGGCGCAGCCATCGCCCGTGCGATCCTGCCGTACCTGGAAGGCATCTGGCGAGAGCCGGACGAGGGGCTGTGGGAGGTGCGGGGCGGCCGCCAGCACTTCGTGCACTCCAAGGTCATGGCCTGGGTTGCCTTCGACCGGGCGGCGGGCCTGGCCGACACCACCGAGGAGGGGCGTGAGCGCAGCCGGCATTACCGCCAGGTGGCGGACGAGATCTGTGACGAGGTCTGCCGGCGCGGGCTGGACGCCGGCGGCCGGCACTTCGTCCAGGCCTACGGCTCGACGGAGCTGGACGCGAGTCTGCTGCAGATCGCCCTGACCGGCTTTCTGCCGGCCGACGATCCACGCTTTCTGCGCACCCTGGAACAGATCGAAAGGCGCCTGCTGCGCAACGGCCTGCTGCTGCGCTACGACAGCGACAGTTGCAGCGACGGCCTGACGCCGGGGGAGGGGACGTTCCTGGTGTGTTCGTTCTGGCTGGCGGATGTGTATGTGCTGCTGGGGCGGCAGGACGAGGCGCAGGTGCTGTATGAGCGACTGACGGGCTTGTGCAATGACGTGGGGCTGCTGGCCGAACAGTACGACCCGGCGGGCAAGCGGATGCTGGGGAATTTTCCGCAGGCGTTCAGCCATATCGGGATCATCAATACGGCGTTGAACCTGCACCGGGCGCAGTGTCCGGTGCGGGATCGGGCGGGGGGCAGTTGA	MPAHIEDYALIGNCRSAALINRDGALDWLCLPRFDAPAVFAALLGNEENGRWRIAPSDPVEHSARRYLDDTLVLETTWTTASGRARVLDCMPLGERNAVLRIVEGLAGETAFEMDLVLRFDYGRSVPWVEKIDPLTLSAVAGPDRLILRSSTEIHGRDHHSVARFRVGAGQRQVFSLCHQASHLPVQPECDIDHDFEQTLEQWRAFAARCPDVGPYTDRVRRSLLTLKAMTYAPTGGMVAAVTTSLPERVGGERNWDYRYCWLRDATMTLLALMNLGYFDEAQAWREWLLRSVAGNPEQMQIMYGLAGERDLPEFTLPWLPGYEGSQPVRVGNAAAGQLQLDIYGELADAMTQAIKGGLPRHSRGAAIARAILPYLEGIWREPDEGLWEVRGGRQHFVHSKVMAWVAFDRAAGLADTTEEGRERSRHYRQVADEICDEVCRRGLDAGGRHFVQAYGSTELDASLLQIALTGFLPADDPRFLRTLEQIERRLLRNGLLLRYDSDSCSDGLTPGEGTFLVCSFWLADVYVLLGRQDEAQVLYERLTGLCNDVGLLAEQYDPAGKRMLGNFPQAFSHIGIINTALNLHRAQCPVRDRAGGS	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	58.11	gnl|BL_ORD_ID|4683|hsp_num:0	1647			1989	2079	acriflavine; tetracycline; norfloxacin
BGC0001285.1|Pseudopyronine_7 # 6321 # 7370 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.580	BGC0001285.1|Pseudopyronine_7 	6321	7370	+	Loose	100	29.261	FosA8	34.88	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAAGATCGTCGGACTTTCCGCAATACTGCCGTCACGCCAAGTCACCAACCAGGACGTCATCAACCTGGTCGAACAACACTCCAGGGACACCTTCCAGGAGGACTTGCCGAAAACCTTGAAGACCATCGGCAAGTTGCTGGACAAAAGCGGCAGCGATACCCGCCATTGGCTGGCGGCTGACGAGACGCCGATGGCCCTGATGGAAGCAGCATTCGACGCGGCGCTGGCCCAGGCCAATATCAGCAAGGCCGACCTGGACCTGCTGATCTATCCCAACGTCACCCGTGGTTTCATCGAACCGGCCAACAGTACCTTCATCGCCAAGGCGCTGGGCCTGAACTGCCGCAACTTCGATGTGGTCGACGCCTGCAACGGCTGGGTGACGGCCATGGACGTCATCAACAGCAAGATGCAAGCCGGTGAAATCCGCTACGCCGCCATCGTCAACATGGAGTTCGGCATGTCGGAAGGCGGGCCGGTGATGCCCAAGAACTTCTCGTTGCAGTCGTCGGCCGAACTGGCCTACAAGTTCCCGAGCTTTACCATTGGCGAGGCCGCCGTCGTCACCATCCTGAGTAACGAGGCACCGGGGAACTTCAAGTTCTCCTATATCAACCGACCTGATCTGAGTGACTTGTCGACGATCTCCTTGCCGGACTGGAAGCTGTTCTGCAACGAGGCCGATATCGCCAAGATCGAACCGACCGGTGGCCAGTACCAGTTCAACTCCTATGCCGCCGCCTTGCATGAAGACGGGCGCAACGAAGCGATGAAAGTCTTCAACATGCAGAACCTCACCGCAGACGACGTGCACAAAGTGTTCATCCATACCGGTTCGCCAAAGATGTGGGAACACATTGGCCAGATGATTGGCGTCGATCACAAGTTGCATCACGTCGGGCACAAGACCGGCAACATCATTACCGCGTCGATTCCCTTCGGCATCTTTGATGCCATGAGCCGGGGCGAAGCCGAGCCAGGCCAGTTCTGCATGGGCTGGGCGGGCAGTGGCGGGATGGTGTTCTCGGCGCTGTCGTTTACCTTGTAA	MKIVGLSAILPSRQVTNQDVINLVEQHSRDTFQEDLPKTLKTIGKLLDKSGSDTRHWLAADETPMALMEAAFDAALAQANISKADLDLLIYPNVTRGFIEPANSTFIAKALGLNCRNFDVVDACNGWVTAMDVINSKMQAGEIRYAAIVNMEFGMSEGGPVMPKNFSLQSSAELAYKFPSFTIGEAAVVTILSNEAPGNFKFSYINRPDLSDLSTISLPDWKLFCNEADIAKIEPTGGQYQFNSYAAALHEDGRNEAMKVFNMQNLTADDVHKVFIHTGSPKMWEHIGQMIGVDHKLHHVGHKTGNIITASIPFGIFDAMSRGEAEPGQFCMGWAGSGGMVFSALSFTL	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	247.52	gnl|BL_ORD_ID|4906|hsp_num:0	5899			111	240	fosfomycin
BGC0001285.1|Pseudopyronine_8 # 7431 # 8924 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.655	BGC0001285.1|Pseudopyronine_8 	7431	8924	-	Loose	1900	30.8018	MexK	31.68	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAAATCGACCATCCCCGCTGCGCCGCCCTGCACCCTATTCCTGTTCGGCGCCAGCGGCGACCTGGTCAAGCGCCTGCTGATGCCGGCGCTGTACAACCTCAGCCGTGACGGCCTGCTCGATCGCAACATGCGCATCGTCGGAGTCGACCACAATGCCGCCACGGCCGAGGCTTTCGCCGAGCGCCTGCATGCCTTCATGGCCGAGCGCGATGCCGGCAAGTGCCTGGACGAGAAGCTCTGGGCACGCCTGGCCAAGCGCCTGGACTACCAGACCGGCGATTTCCTCGATCCGCAGACTTACCAGGCCCTGGCCCGGCGCATCGACAAGACGCGCCACGGCAACGCCATCTTCTACCTGGCCACCTCGCCACGCTTTTTCCCCGAGGTGGCCCAGCGCCTGGGCGATGCCGGCCTGCTCGACGAGTCGGGCGGTGGCTTTCGCCGGGTGGTGGTGGAAAAGCCCTTCGGCACTGACCTGGCCAGCGCCGAGGCGCTCAACGCCCGCCTGCTCAAGGTGATGAACGAGCGGCAGATCTACCGTATCGACCATTATCTGGGCAAGGAGACCGTCCAGAACATCCTGGTCAGCCGTTTCTCCAACGGCCTGTTCGAATCGTTCTGGAACAATCATTACATCGACCACGTGCAGATCACCGCCGCCGAAACTGTCGGCGTCGAGACGCGCGGGGCGTTCTACGACAACACTGGCGCCCTGCGCGACATGGTGCCCAACCACCTGTTCCAGTTGCTGGCCATGGTCGCCATGGAGCCACCGGCGGCCTTCGGCGCCGACGCCGTGCGCGGTGAAAAGGCCAAGGTGATCGGCGCCATCCGCCCCTGGTCGCACAAGATGGCCCTGCGCAATTCCGTGCGTGGCCAGTACAGCGCCGGCAAGCAGGGCCGCAAGCAACTGCCCGGTTATCGCGAGGAGGCCAACGTCGCCCCGCACAGCCAGACCGAGACCTACGTGGCCCTCAAGGTGATGATCGACAACTGGCGCTGGGCCGGGGTGCCGTTCTACCTGCGTACCGGCAAGCGCATGAGCGTGCGCGACACCGAGATCGCCATCTGCTTCAAGCCGGCGCCCTACGCGCAGTTTCGCGAAAGCGAGCTGGAGCGGCCCAAGCCGAACTACCTGAAGATCCAGATCCAGCCCAACGAAGGCATGTGGTTCGACCTGCAGGCCAAGCGCCCGGGGCCGGAGCTGGTGATGGAAAATGTCGAGATGGGCTTCGCCTACAAGGACTTCTTCAAGATGACCCCGGCGACCGGTTACGAGACGCTGATCTACGACTGCCTCACCGGCGACCAGACCCTGTTCCAGCGAGCCGACAACATCGAGAACGGCTGGCGCGCGGTGCAACCGTTCCTCGATGCCTGGGCGGCCGAGGGCGGCGAAGTGCATGGGTATGCGGCGGGGGAGGATGGCCCCGAGGCCGGCGACGAACTGCTGGCGCGGGATAAGCGCGAGTGGCACACGCTGGGGTGA	MSKSTIPAAPPCTLFLFGASGDLVKRLLMPALYNLSRDGLLDRNMRIVGVDHNAATAEAFAERLHAFMAERDAGKCLDEKLWARLAKRLDYQTGDFLDPQTYQALARRIDKTRHGNAIFYLATSPRFFPEVAQRLGDAGLLDESGGGFRRVVVEKPFGTDLASAEALNARLLKVMNERQIYRIDHYLGKETVQNILVSRFSNGLFESFWNNHYIDHVQITAAETVGVETRGAFYDNTGALRDMVPNHLFQLLAMVAMEPPAAFGADAVRGEKAKVIGAIRPWSHKMALRNSVRGQYSAGKQGRKQLPGYREEANVAPHSQTETYVALKVMIDNWRWAGVPFYLRTGKRMSVRDTEIAICFKPAPYAQFRESELERPKPNYLKIQIQPNEGMWFDLQAKRPGPELVMENVEMGFAYKDFFKMTPATGYETLIYDCLTGDQTLFQRADNIENGWRAVQPFLDAWAAEGGEVHGYAAGEDGPEAGDELLARDKREWHTLG	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	48.49	gnl|BL_ORD_ID|2016|hsp_num:0	2206			1680	1950	erythromycin; tetracycline; triclosan
BGC0001285.1|Pseudopyronine_9 # 8925 # 9908 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.687	BGC0001285.1|Pseudopyronine_9 	8925	9908	-	Loose	300	28.4906	DfrA38	25.61	3005349	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCAACTGGGAATCATCGGGCTTGGCCGCATGGGCGGCAATATCGCAAGGCGCCTGATGCGCGCAGGTCACAGCACTGTGGTCCACGATCGCAACCGCGAAGCCATCACCACCCTGGAAGGCGAAGGTGCCGTGGGCGCCCACGACCTCGGTGCGCTGGTGCAGAAACTCAAGGCGCCGCGGGCAGTGTGGGTCATGCTGCCGGCGGGCGAAATCACCGAGCAGACCATCGCCCAGCTGGCCGACCTGCTCGAGCCGGGTGACGCCATCATCGATGGCGGCAACACCTTCTACAAGGACGATGTGCGCCGCGCCGCCGAGCTGGGCAAGCGTGGCCTGCACTACCTCGACGTCGGCACCTCCGGCGGCGTGTGGGGCCTGGACCGTGGCTACTGCATGATGATCGGCGGCGAGAAGGCGGTGTTCGAGCGCCTGGAACCGCTGTTCGAGGCCCTCGCCCCGGGCGTCGGCGACATTCCGCGCACCCAGGGCCGCAGCGGCGAGCACGAGCGCGCCGAGCACGGCTACATCCACGCCGGCCCGCCCGGTGCCGGCCACTACGTGAAGATGGTGCACAACGGCATCGAGTACGGCCTGATGCAGGCCTACGCCGAAGGCTTCGACCTGCTGCGCAGCAAGGGCGGCCCGGAACTGCCGGAGGACCAGCGCTTCGACCTGAATGTGGCCGAGATCGCCGAAGTGTGGCGCCGCGGCAGCGTGGTCACCTCCTGGCTGCTGGACCTGACCGCCGACGCGCTGGTCGCCGACCCACAACTGACCGAGTTCAGTGGCTCGGTGTCCGACAGCGGCGAAGGCCGCTGGACCATCGACGCCGCCGTCGAGCAGGCCGTGCCGGTGCCGGTGCTGTCCAGCGCGCTGTTCGCCCGCTTCCGCTCGCGCCAGCAGCAGGGCACCTACGGTGACAAGATCCTTTCCGCCATGCGCCTGGGCTTTGGCGGCCACGTCGAGAAGAAGAAGGACTGA	MQLGIIGLGRMGGNIARRLMRAGHSTVVHDRNREAITTLEGEGAVGAHDLGALVQKLKAPRAVWVMLPAGEITEQTIAQLADLLEPGDAIIDGGNTFYKDDVRRAAELGKRGLHYLDVGTSGGVWGLDRGYCMMIGGEKAVFERLEPLFEALAPGVGDIPRTQGRSGEHERAEHGYIHAGPPGAGHYVKMVHNGIEYGLMQAYAEGFDLLRSKGGPELPEDQRFDLNVAEIAEVWRRGSVVTSWLLDLTADALVADPQLTEFSGSVSDSGEGRWTIDAAVEQAVPVPVLSSALFARFRSRQQQGTYGDKILSAMRLGFGGHVEKKKD	MNCCIVVGIGRNREIGKNNDLPWHLPRDMQFFKETTTGHIVVMGRKNWESIPDKFRPLPNRVNIVLTRNKDYKAEGALVIHDWSELEQHLSADKTCFIIGGSEIFKQALDAGLVNEMYITHIDATFEGADVFFPYVNWENWTEEDILHYTKDEKNPYSFTIKKYSK	196.99	gnl|BL_ORD_ID|3055|hsp_num:0	4081			186	399	trimethoprim
BGC0001285.1|Pseudopyronine_10 # 10105 # 10272 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.661	BGC0001285.1|Pseudopyronine_10 	10105	10272	+	Loose	500	27.335	TEM-102	33.33	3000965	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGGGTACCCTGATGCCAGCCACTCCCACCCAGACCCTCTATGTCACCGTGCGCCGCGACGAGCTGCGCCAGTTGAAGGACGAACGTGACCAGTTGCGTCAGCAGGTCGCCCAGCTGAACCTGCTGCTCGAGCAGGCCCGCGTGCACGGCAAGGCCGCCGGTCTCTGA	MGTLMPATPTQTLYVTVRRDELRQLKDERDQLRQQVAQLNLLLEQARVHGKAAGL	MSIQHFRVALIPFFAAFCLPVFVRPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAAVGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	19.23	gnl|BL_ORD_ID|75|hsp_num:0	86			27	162	ampicillin
BGC0001285.1|Pseudopyronine_11 # 10765 # 12324 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.665	BGC0001285.1|Pseudopyronine_11 	10765	12324	+	Loose	300	27.7202	dfrA16	30.77	3003014	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGATCAGTGCCGCTGTCGAACCTCACGTAGAATCATTCAACCCGGATAGCCGCGAGCCGCTGCCAGCGGCGCTCGCTCCGACAGTCAAGGCACCCGGCGCCCAGCGCCAGCACAATCCGAACAAGCGCAAGATCCTGTTCGTCACCTCGGAGATCGCCGACCTGGTCAAGACCGGCGGCCTGGGCGACGTGTCCTCCGCCCTGCCCCGCGCCCTGGCGCATTTGCACGATGTGCGGGTGCTGATCCCCGGTTACCGGCAGGTAATGGAAAGCGACAACCCCATCCATATCGTCGGCGAACTGGGTGGCCACGCAGCCCTGCCACCGTGCAGGATCGGCCGCATGGACCTGGCCGACGGCCTGGTGATCTACGTGCTGATCTGCCCCGAGCTGTACCAGCGCGACGGCACGCCCTACGGTGCCAACAACGGCCGCGACTGGCCCGACAACCATATCCGCTTCGCCCGCCTGGGCTTGGCGGCGGCGGAAATCGCGGCTGGCGAAGGCATGGCCCACTGGCGCCCCGACCTGGTGCACGCCCACGACTGGCCGGCCGGGCTGGCCCCGGCCTACATGCACTGGCGCGGCTTGAGCACCCCGACCCTGTTCACCATCCACAACCTGGCCTATCAGGGCGTGTACAGCCGCGGCTGCAGCCCGGAGCTGGCGATCCCCGACCACGCCATGCAACAGGAAGGCATGGAGTTCTACGGCAAGCTGTCGTTCCTCAAGGCCGGCCTGGCGTACTCCAGCCACATCACCACGGTCAGCGCCACCTATGCCCGGGAGATCACCACCCCCGAGTTCGGCTGCGGCCTGGACGGTTTCCTGGCCAGCAAAGCGCAACAAGGACTGCTCGGCGGCATCCCCAACGGCATCGATGAAAGCTGGGACTCGGCCACCGACCAGCACCTGCACCACAATTTCAGCCTCAACGACTGGGCCGGCAAGGCGCGCAACGCCCAGCAGGTACGTGAGCTGTTCGAACTGGAGCCGTCGGACGGTCCGCTGTTCGCCGTGGTGTCGCGGCTGGTCTACCAGAAAGGCCTGGACCTGACCCTGGGGGTGGCCGACTACATCGTCCAGCAGGGCGGCCAGATCGCCATCATCGGCCGCGGCGAACCCGAGGAGGAACAGGCCATGCGCGAGCTGGCCCTGCGTCATCCGGGCCGTATCGGCGTGCGCATCGGCTTCAACGAGACCGACGCCCGGCGCATGTTCGCAGGCAGTGACTTCCTGCTGATGCCGTCGCGCTACGAGCCTTGCGGCCTGAGCCAGATGTACGCCCAGCGCTTCGGCTCGCTGCCAGTGGCGCGCAACACCGGTGGGCTGGCCGACACCATCGAGAACGGTGTCACCGGCTTTTTGTTCGACGATTCGACCGTCGACAGCTACCGCGAGGCCCTGGCCCGCGCCTTCTACGTGTACGGCAAGAAGAGCCTGTTGAACGCCATGCGCTGCCTGTCGATGACCCAGCCGTTCAACTGGTGCCAGGCGGTGGAGCCCTATGCACGCCTGTACGAGGACTTGGTCAAGCAGGCGCAGCACAGCCACTACTGA	MISAAVEPHVESFNPDSREPLPAALAPTVKAPGAQRQHNPNKRKILFVTSEIADLVKTGGLGDVSSALPRALAHLHDVRVLIPGYRQVMESDNPIHIVGELGGHAALPPCRIGRMDLADGLVIYVLICPELYQRDGTPYGANNGRDWPDNHIRFARLGLAAAEIAAGEGMAHWRPDLVHAHDWPAGLAPAYMHWRGLSTPTLFTIHNLAYQGVYSRGCSPELAIPDHAMQQEGMEFYGKLSFLKAGLAYSSHITTVSATYAREITTPEFGCGLDGFLASKAQQGLLGGIPNGIDESWDSATDQHLHHNFSLNDWAGKARNAQQVRELFELEPSDGPLFAVVSRLVYQKGLDLTLGVADYIVQQGGQIAIIGRGEPEEEQAMRELALRHPGRIGVRIGFNETDARRMFAGSDFLLMPSRYEPCGLSQMYAQRFGSLPVARNTGGLADTIENGVTGFLFDDSTVDSYREALARAFYVYGKKSLLNAMRCLSMTQPFNWCQAVEPYARLYEDLVKQAQHSHY	MKLSLMAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSNFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDIERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS	330.57	gnl|BL_ORD_ID|545|hsp_num:0	598			12	120	trimethoprim
BGC0001285.1|Pseudopyronine_12 # 12339 # 14081 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0001285.1|Pseudopyronine_12 	12339	14081	+	Loose	1800	28.4906	mdtB	45.71	3000793	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACAGGCATGGCGCACACCTGCTGGACGCCACGTCGGCGCGCTTCGCCCTCTGGGCGCCGGATGCGCGCAGCGTGAGCGTGGAACTGGAGCAGCAGCCGGCGATCGAGCTGTTGCCCGACGGTGACGGCTGGTACACCGGCGTGGCCCCGTGCCGGGCCGGTGACCGTTACCACTACCGTATCGACAATGCACTGAAGGTGGCCGACCCGGCCTCGCGCTATCAGCCCGATGGCGTACAGGGGCCGAGCCAGGTGGTGGATGTGGCCAGCTACGCTTGGCGACACCCCTGGCAGGGCCTCCCCTGGCACGAAGCGGTCATCCAGGAGCTACATGTCGGCTTGCTCGACGGCTACGTCGGGGTGGCCCGGCACCTGCCGCGTCTGGCCGAACTGGGCATCAGCGCCGTCGAACTGATGCCGCTGGGACAGTTCCCTGGCGAGCGGAACTGGGGGTACGACGGCGTGCTGCCCTATGCGCCGCAAAACACCTATGGCAGTCCCGAGCAATTGTGTGAGCTGGTCGACCAGGCACATGGCCAGGGGCTGATGGTGCTGGTCGATGTGGTGTACAACCATTTTGGCCCCGACGGCAATTACCTGCAGCAGTACGCCAGCCCATTTTTTCGCGAGGACCGGCAGACTCCCTGGGGTGCAGCCATCGACTTCCGTCGCCCGCAGGTGCGCGAGTACTTCATCCAGAACGCCCTGATGTGGTTGTGCGACTACCGCATTGATGGCCTGCGCCTGGATGCCGTGCACGCCATCGATCAGCCCGACTTCCTGGTCGAGTTGGCGCAACGGGTACGCGCGGCCGTGGAGCCGGGCCGTCACGTATGGCTGGTGCTGGAAAACGAGCACAACCAGGCCGCACTGCTGCAGCAAGGCTTCGACGCGCAGTGGAACGACGATGGCCACAACGCCCTACATGTGTTGCTGACCGGCGAGACCGAAGGCTACTACGCCGACTACAAGGACCGACCGATCAACCAACTGGCCCGCTGCCTGGCCGAAGGCTTCGTGTTCCAGGGCCAACCCGACCGCCACGGCACGCCCCGCGGCGAGCCCAGCGGCCACCTGCCACCGAGCGCCTTCGTGCTGTTTTTGCAGAACCACGACCAGATCGGCAACCGCGCCCTGGGTGAACGCCTCACCCGCCTCTGCCCACCGCCGGCCCTGCGCGCCGCCACCGCGCTGCTGCTGCTGGCGCCGATGATCCCGCTGCTGTTCATGGGCGACGACGACGGCAGCCGTGAGCCGTTCCTGTTCTTCACCGATTTTCACGATGAGCTGGCCGACGCCGTGCGTGAGGGCCGCCGCGGCGAGTTCGCCCATTTCGACGCCTTCGCCGATCCGCACAAGCGCGAGCAGATACCCGACCCGAATGCCGAGGCGACCTTCGCCTCATCCAGGCCCCGGCAACGGAATGTACTGGCCGGCTGGCACGGTCTGTACCAGCAATTGCTCGACCTGCGCCGGCGCCATGTCGTACCGCACCTGCCCGGCGCACGCGCCCTCGGCAGCGAGGTGCTCGGCGACCAGGCGCTGACCGCCCGCTGGCGCCTGGGCAATGGCGACGAGCTGCGCATCGACCTCAACCTCGCCGCCCAACCCCAGCCGGTCGCGCTGCCCGCCCTTCAGCGGCGCCTGTACGACAGCAGCGACAACGCCCACCCCGACTCGGCCCTCGCCGCGCACAGTTGCGTGGTCAGCCTACTGCCCCCCGACCAGGAGACGCCATGA	MHRHGAHLLDATSARFALWAPDARSVSVELEQQPAIELLPDGDGWYTGVAPCRAGDRYHYRIDNALKVADPASRYQPDGVQGPSQVVDVASYAWRHPWQGLPWHEAVIQELHVGLLDGYVGVARHLPRLAELGISAVELMPLGQFPGERNWGYDGVLPYAPQNTYGSPEQLCELVDQAHGQGLMVLVDVVYNHFGPDGNYLQQYASPFFREDRQTPWGAAIDFRRPQVREYFIQNALMWLCDYRIDGLRLDAVHAIDQPDFLVELAQRVRAAVEPGRHVWLVLENEHNQAALLQQGFDAQWNDDGHNALHVLLTGETEGYYADYKDRPINQLARCLAEGFVFQGQPDRHGTPRGEPSGHLPPSAFVLFLQNHDQIGNRALGERLTRLCPPPALRAATALLLLAPMIPLLFMGDDDGSREPFLFFTDFHDELADAVREGRRGEFAHFDAFADPHKREQIPDPNAEATFASSRPRQRNVLAGWHGLYQQLLDLRRRHVVPHLPGARALGSEVLGDQALTARWRLGNGDELRIDLNLAAQPQPVALPALQRRLYDSSDNAHPDSALAAHSCVVSLLPPDQETP	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	55.77	gnl|BL_ORD_ID|757|hsp_num:0	820			1350	1440	novobiocin
BGC0001285.1|Pseudopyronine_13 # 14078 # 16147 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718	BGC0001285.1|Pseudopyronine_13 	14078	16147	+	Loose	800	29.6462	msrA	30.77	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGAGCGAACAGCCCCTCCACCGCCTGGCCGCGCGGGTCGGCCTGGCCCGCGACTGGATCGATGCCAACAACCGCCCGCAGCAGGTCAGCGACGAGGTATTGCGCCGAGTGCTCGCAGGCCTCGGCCACCCGGCCGGCGATGCCGCCGCCATCGCTGCCAGCCTGCGCGCCGTCGAGCAAGCCGAGGACAGCGAGCACCTGCCGCCACTGCTGACCGTCGATATCGGCCAGCCCCTGGACCTGCGGCGCTATTTCACCGCCGACCGCCAGGCGCACTGCACACTGGAGGACGGCAGCCTCCGCCACCTGGCCCTGGACACCCAGGCGCGGTTGCCGGGCGAGCTGCCGCTGGGCTACCACCGGGTTGACATCGATGGCCGCAGCTTCAGCGTGGCCGTGGCGCCGCCGCGCTGCCATGCCCTGGAGGACCGCGTCGAGCAGCAACCGCCGCGCTGCTGGGGCATCGCGGCGCAGCTGTACAGCCTGCGCCGCCCCGGCGATGGCGGCTACGGCGACTGCCTGGCCCTGGAGCAACTGGCGCGCAACGCCGCAGAGCGCGGCGCCGATGCCTTGGCGATCAGCCCGATCCACACCCTGTCGGCGTTCGATCAGCGCCACTTCAGCCCCTACTCGCCCTCCAGCCGGCTGCTGCGCAACGTGCTGTACGCCAGCCCCGGTGTGGTCTTTGGCGAGCGCGAGGTGCGCATGGCCATCGAGGCCTGCGACCTGCAGGCGACCCTCGACACGCTGGAGCAGCAGGCGCTGGTGGACTGGCCACGGGCCGCCGATGCCCGCCTGCGCCTGCTCGAGGCGCTCTACCGGCAGTTCAGCCAGGGCGAGCATCCATTGCGCGAGGACTTCGAGAGTTTCCGCGCCAGCGCCGGCGAGCGACTGGAGCACCATTGCCGCTTCGAAGTGCTGCAGGCGGAAGCTGTCAGTACGGGCCTGGGCGCCGACTGGCGCCGCTGGCCCAAGGCCTGGCACGACCCCTACCACCCCGAGGTCGAAGCCTTCGCCAACGCCTATCCGGCGCGGGTCGAGTTCCACGCGTTCTGCCAGTGGCTGACCGAGCGCAGCCTGCAGCGGGCCCAGGACGCGGCGCGCGGCAACGGCATGGCGGTAGGCCTGATCGCCGACCTGGCGGTGGGGGCCGACGGCGCCGGCAGCCAGGCCTGGAGCCGCCAGGACGAACTGCTGGCCGAGCTCAAGGTCGGCGCGCCACCGGACATCCTCAACCGCTCCGGCCAGGATTGGGGCATCTGCGCCTTCTCCCCCGAAGGCCTCAGGCGCAACGGCTACCGCGCGTTCATCGAGATGCTGCGGGCCAACCTGGCCCATGCCGGTGGCCTGCGCATCGACCATGTGATGGGCCTGCGCCGACTGTGGCTGATCCCCCGCGGCGCCAAGCCGAGCGAAGGCGCCTACCTGGACTATCCGCTGGACGACCTGCTACGCCTGCTGGCGCTGGAATCGGCGCGACACCAGGCGATCATCCTCGGTGAAGACCTGGGCACCGTGCCCGAGGGCCTGCGCGAACGCCTGGCCGACAAGGCCGTGCTGGGCATGCGCGTGCTGCCGTTCGAGCAGGCCGCGCCCGGACAGCTCAAGCCGATCCTCGACTGGCCGGACAATGCCCTGGCCACCACCGGCACCCACGACCTGGCGCCCCTGGCCGGTTGGCTAGCGGGCCGCGACATCGACTGGAGCCATCGCCTGCAACTGATCGACGCCGCCACCGAGCTGCACTGGCGCCACACCCGGGCCCTGGAACGCGACGGCCTGCGCCGCACCCTGGAGCAGAACTACGGGCCACTGCGCGGCGACGACGCGCTGATCGACGCGGCGATCCGCTATGTTGGCCACACCCGCGCCCCCCTGGTACTGGTGCCGCTGGAAGACCTGCTGGGCAGTGACGAGCAGGCCAACCTGCCCGGCACCACCGAAGGCCACCCCAACTGGCGCCGGCGCTTCAAGGCGCCAGCATGCGACCTGCTCGACGACGAGGACGCCGCCCGCCGCCTGGAGCTGCTGGCCCAGGCTCGCGAACAGGCCTGGGAGCGTGACCGATGA	MSEQPLHRLAARVGLARDWIDANNRPQQVSDEVLRRVLAGLGHPAGDAAAIAASLRAVEQAEDSEHLPPLLTVDIGQPLDLRRYFTADRQAHCTLEDGSLRHLALDTQARLPGELPLGYHRVDIDGRSFSVAVAPPRCHALEDRVEQQPPRCWGIAAQLYSLRRPGDGGYGDCLALEQLARNAAERGADALAISPIHTLSAFDQRHFSPYSPSSRLLRNVLYASPGVVFGEREVRMAIEACDLQATLDTLEQQALVDWPRAADARLRLLEALYRQFSQGEHPLREDFESFRASAGERLEHHCRFEVLQAEAVSTGLGADWRRWPKAWHDPYHPEVEAFANAYPARVEFHAFCQWLTERSLQRAQDAARGNGMAVGLIADLAVGADGAGSQAWSRQDELLAELKVGAPPDILNRSGQDWGICAFSPEGLRRNGYRAFIEMLRANLAHAGGLRIDHVMGLRRLWLIPRGAKPSEGAYLDYPLDDLLRLLALESARHQAIILGEDLGTVPEGLRERLADKAVLGMRVLPFEQAAPGQLKPILDWPDNALATTGTHDLAPLAGWLAGRDIDWSHRLQLIDAATELHWRHTRALERDGLRRTLEQNYGPLRGDDALIDAAIRYVGHTRAPLVLVPLEDLLGSDEQANLPGTTEGHPNWRRRFKAPACDLLDDEDAARRLELLAQAREQAWERDR	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	141.19	gnl|BL_ORD_ID|1105|hsp_num:0	1200			372	555	erythromycin; quinupristin
BGC0001285.1|Pseudopyronine_14 # 16144 # 17370 # 1 # ID=1_14;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.688	BGC0001285.1|Pseudopyronine_14 	16144	17370	+	Loose	510	28.4906	OXA-277	54.17	3001733	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACCGTTGACCGCGACCCTGCGACTGCAACTGCACAGCGACTTCACCCTGGATGACGCGGTGCCGCTGGTGCCCTACTTCGCCCGCCTTGGCATCAGCCACCTGTACGCTTCGCCGATCCTCACCGCCCGCGCCGGTTCCCGGCATGGCTACGACGTGGTCGACCCGACCCGGGTCAACCCGGAGCTTGGCGGCGAGGCGGCGCTCGAACGCCTGGTGGCCGCGTTGCGCCAGCACGGCATGGGGCTGATCCTCGACACCGTGTCCAACCACATGGCCGTCGGCGGCGCCGACAATCCCTGGTGGCAGAGTCTGCTGGCCTGGGGCCGGCGCAGCCCCTATGCGGAATTCTTCGATATCCAGTGGCATTCCAGCGACCCGTTGCTGGCCGGGCAACTGTTGCTGCCGTTCCTGGGCAGCGATTACGGCGCGGCCCTGCAAAACGGCGAGATCCCGCTGACCTTCGAGGCGCCACAGGGGCGTTTCGAGGTGGCCCACCATGAACATCGCTTCCCGATCTGTCCGCTGGACTACGGGCGCATCCTCGATCAGGCCGAGGATCCGCGCCTGCAGGCACTGGCCGCGCACTTCAGCGCCCTCGGCGAGGCCGACGACCCACTGGCCGCGGCCCTGTCCCTGCAGCACGAGCTGGCGCGCCTGGCCGCCGCCGGCGCGGACCTGCAAGCGGCCCTCGGCGCCTTCGACAGCCGCACCGAGGCCGGTTTCAAGCGCCTGCACCTGCTGCTGGAACGCCAGACCTACCGCCTGGCCAGCTGGCGCACCGCCGCCGACGACATCAACTGGCGGCGCTTCTTCGACATCAACGAACTCGGTGGCCTGCGCGTCGAGCGCGCGGTGGTGTTCGAGGCCACCCATGCCAAGCTGTTCGAGCTGATCGAACGCGGCCTGGTGGACGGCCTGCGCATCGACCATATCGATGGCCTGGCCGATCCGCGACGCTACTGCCGCAACCTGCGCCGCCGGGTCGACCGCTTGCTGGCGCGACGGCCACTGGATGCCGCACTGGCGCACTTCCCGATCTATGTGGAGAAAATCCTCGGCACCGACGAACACCTGCACCGCGACTGGCTCACCGACGGTACCACCGGCTACGAGTTCATGAACCAGGTGTCGCTGCTGCAGCACGATCCCGCCGGCGAGGGGCCGCTGGGCGAGTTGTGGAACAGCGTCAGCGAGCGCCCCGAGTTCGCCGAGGAGGTGCGC	MKPLTATLRLQLHSDFTLDDAVPLVPYFARLGISHLYASPILTARAGSRHGYDVVDPTRVNPELGGEAALERLVAALRQHGMGLILDTVSNHMAVGGADNPWWQSLLAWGRRSPYAEFFDIQWHSSDPLLAGQLLLPFLGSDYGAALQNGEIPLTFEAPQGRFEVAHHEHRFPICPLDYGRILDQAEDPRLQALAAHFSALGEADDPLAAALSLQHELARLAAAGADLQAALGAFDSRTEAGFKRLHLLLERQTYRLASWRTAADDINWRRFFDINELGGLRVERAVVFEATHAKLFELIERGLVDGLRIDHIDGLADPRRYCRNLRRRVDRLLARRPLDAALAHFPIYVEKILGTDEHLHRDWLTDGTTGYEFMNQVSLLQHDPAGEGPLGELWNSVSERPEFAEEVR	MKILILWPLLSCLSLTACSFAVSNSPSQITSTQSIQATAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYVPASTFKMFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKITPKQEVEFASALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVVFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEA	148.19	gnl|BL_ORD_ID|2593|hsp_num:0	3443			561	633	cloxacillin; oxacillin; cefalotin
